Abnormal left ventricular (LV) diastolic relaxation is an early sign of hypertensive heart disease. Whether LV diastolic dysfunction is caused directly by raised blood pressure, or by structural changes related to LV hypertrophy remains controversial. We examined 115 hypertensive patients with LV hypertrophy, and two ageand gender-matched groups (38 hypertensive patients without LV hypertrophy and 38 normotensive subjects) by echocardiography to assess determinants of LV diastolic function, and the relation between diastolic function and LV geometric pattern. Diastolic function was evaluated by the E/A-ratio, E wave deceleration time (E-dec), isovolumic relaxation time (IVRT), and the atrioventricular plane displacement method (AV-LA/AVmean). A multivariate analysis (including gender, age and body mass index) shows diastolic function to be inversely related to blood pressure, LV wall thickness and LV mass, but not to LV end diastolic diameter. The E/A-ratio generally showed the strongest relations. Only the E/A-ratio and AV-LA/AV-mean were related to heart rate. By stepwise regression analysis, age was the strongest determinant for the E/A-ratio, E-dec and AV-LA/AV-mean, followed by systolic blood pressure, heart rate and LV wall thickness. For IVRT, however, LV wall thickness appeared strongest, followed by systolic blood pressure and age. In conclusion, blood pressure and LV wall thickness both have independent influence on LV diastolic function. Age and blood pressure are the most important factors to determine the E/A-ratio and Edec, whereas LV geometry and blood pressure are most important when IVRT is used. AV-LA/AV-mean may not be useful in hypertensive LV hypertrophy.
Introduction
Left ventricular (LV) hypertrophy represents an independent strong risk factor for cardiovascular morbidity and mortality. 1, 2 Furthermore, a reduction in LV mass by antihypertensive treatment reduces the risk for subsequent cardiovascular events. 3, 4 In addition to LV hypertrophy itself, the LV geometric pattern also provides additional important prognostic information. Thus, patients with concentric LV hypertrophy have the greatest risk for future cardiovascular events. 5 An abnormal diastolic relaxation in the absence of systolic impairment is often seen in patients with hypertension, whether LV hypertrophy is present or not. 6 Diastolic dysfunction is considered an early sign of hypertensive heart disease and may eventually progress to heart failure. Indeed, hypertensive heart disease is a major aetiology for congestive heart failure and accounts for more than half of all patients with heart failure. 7 It is difficult to precisely evaluate LV diastolic functions, as it may be influenced by many factors including age, heart rate, left atrial pressure, contractility and compliance and LV systolic function. [8] [9] [10] Whether LV diastolic dysfunction is caused directly by raised blood pressure itself, or by structural changes related to LV hypertrophy remains controversial. The aims of this study were to assess determinants of LV diastolic function, and to evaluate the relation between diastolic function and different LV geometric patterns. Thus, we assessed LV diastolic function using different echocardiographic measurements, blood pressure, LV mass and geometric patterns in a large sample of subjects including normotensive and hypertensive subjects and patients with LV hypertrophy.
Materials and methods

Design and study population
This study examined 115 Caucasian patients with primary hypertension and LV hypertrophy, verified with echocardiography, who subsequently took part in the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. 11 Three patients with LV hypertrophy were excluded from the echocardiographic evaluation because of unsatisfactory registrations and one patient with LV hypertrophy was excluded from all analyses due to a diagnosis of Conn's syndrome after completion of the study. In addition, we examined two age-and gender-matched control groups consisting of 38 hypertensive patients without LV hypertrophy and 38 healthy normotensive subjects, respectively. The patients with LV hypertrophy were grouped by age and gender, and for every three patients, one subject for each control group was selected. Exclusion criteria were a LV ejection fraction o45%, any history or clinical signs of congestive heart failure (a standard X-ray examination was performed in each subject), a history or symptoms suspicious of coronary heart disease, or any other cardiovascular or other diseases or medications that might interfere with the assessments. Thus, subjects with normal LV systolic function or mild asymptomatic LV systolic dysfunction 12 and an ejection fraction X45% were eligible for the study. All antihypertensive drugs were withdrawn for 4-6 weeks, and the hypertensive patients were considered eligible if seated diastolic blood pressure was 90-115 mmHg. For the normotensive subjects, a seated diastolic blood pressure below 80 mmHg was required for entry into the study.
The study was approved by the Ethics Committee of Karolinska Institutet and all appropriate institutions, and was conducted in accordance with the Declaration of Helsinki. All participants gave their written informed consent.
Measurements and calculations
Echocardiography
Echocardiographic measurements were performed with the patient in the left semilateral position. The ultrasound devices used were the Acuson 128 XP/10 (Mountain View, CA, USA), Vingmed CFM 750 (Vingmed Sound, Horten, Norway) and HP SONOS 2500 (Hewlett-Packard, Andover, MA, USA). For validity, all echocardiographic recordings were stored on videotape and were analysed at the core laboratory by the end of the study. All analyses were performed using dedicated computer equipment and software (TomTec Imaging Systems Inc, CO, USA), as presented in detail elsewhere. 11 In short, measurements were performed on three to five consecutive beats, from which the mean values were calculated. LV dimensions and diastolic filling measurements were evaluated by two persons who where blinded for subject identification, and the mean values were used. Basic measurements of LV dimensions in systole and diastole (LVEDD), and interventricular septum (IVS) thickness and posterior wall thickness (PWT) in diastole were made by M-mode technique. We calculated LV mass (g) as 1.04[(IVS+LVEDD+PWT) 3 ÀLVEDD 3 ]À13.6, and indexed LV mass for body surface area (ie, LV mass index), according to the Penn convention. 13 LV hypertrophy was defined as a LV mass index 4131 g/m 2 for men and 4100 g/m 2 for women. 14 The relative wall thickness (RWT) was calculated as (IVS + PWT)/LVEDD, and RWT 40.45 was considered to be an increased wall thickness. 15 On the basis of LV morphology, patients were classified into four categories: concentric hypertrophy (LV hypertrophy and increased RWT), eccentric hypertrophy (LV hypertrophy and normal RWT), concentric remodelling (normal LV mass and increased RWT) and normal geometry (normal LV mass and normal RWT). Inter-and intraobserver coefficients of variation of LV mass index were 15 and 1%, respectively.
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LV volumes were calculated from area tracings, using the disc summation method (modified Simpson's rule) and the ejection fraction was calculated as (end diastolicÀend systolic)/end diastolic volumes. 16 Normal LV systolic function is often considered present with an ejection fraction above 50-55%. For this report, we defined normal LV systolic function as an ejection fraction X50%, as proposed elsewhere. 12 The atrioventricular plane displacement was measured by M-mode from the motion of the mitral annulus at four sites (septal, lateral, posterior and anterior) in the apical window and calculated according to Hö glund et al.
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Diastolic filling was assessed by Doppler mitral inflow velocities, using the four-chamber view with the sample volume of the pulsed Doppler signal placed at the level of the mitral leaflet tips. From the peak of early (E) and peak of late (A) diastolic velocities, the E/A-ratio was calculated. The E wave deceleration time (E-dec) was measured from the peak of the E wave velocity to the point where its descending slope intercepted the baseline. The isovolumic relaxation time (IVRT) was measured as the interval occurring between the end of the systolic output flow and the transmitral E wave onset by placing the sample volume between outflow and inflow tracts.
Diastolic filling was further assessed by the motion caused by atrial contraction. This was recorded with M-mode in four-and two-chamber views from the diastolic phase when the atrioventricular plane moves from the transducer and apex towards the atrial roof. The last part of the diastolic atrioventricular plane displacement is due to atrial systole. 18 The contribution of atrial systole to left ventricular filling was calculated from the ratio of the magnitude of motion due to atrial systole to the total diastolic atrioventricular plane displacement (AV-LA/AV-mean), according to Alam and Hö -glund. 19 Inter-and intraobserver coefficients of variation of (as evaluated in 20 subjects) AV-LA/ AV-mean were 4 and 2%, for E/A-ratio 3 and 2%, for E-dec 2 and 5% and for IVRT 5 and 5%, respectively.
Blood pressure and heart rate After resting for at least 10 min in seated position, systolic and diastolic blood pressures were determined as the average of three replicate measurements taken 1 min apart using a mercury sphygmomanometer. Pulse pressure was calculated as the difference between systolic and diastolic blood pressure. Heart rate was recorded in the seated position.
Statistical methods
Results are reported as mean values 7 s.d. Statistical evaluation was performed by analysis of variance and post hoc testing according to TukeyKramer. Stepwise regression analyses were performed by multivariate analysis of variance. All statistical tests were carried out to a significance level (P) of 0.05. The sample size of 115 patients with primary hypertension and LV hypertrophy were selected as described elsewhere. 11 There were two control groups consisting of 38 hypertensive patients without LV hypertrophy and 38 normotensive subjects, respectively. We calculate this study to have a statistical power 40.90 to detect a true difference in LV diastolic function between the groups, whether assessed by a difference in the E/Aratio of 0.05, or a difference in IVRT of 5 ms. The statistical program used was JMP, Version 4.0 (SAS Institute Inc, Cary, NC, USA).
Results
General
The characteristics of the three study groups, carefully matched for age and gender, are presented in Table 1 . As expected, there were incremental increases in body mass index, blood pressures and determinants of LV mass from the normotensive group to the hypertensive group without LV hypertrophy, and further to the group with LV hypertrophy. The LV systolic function in relation to LV geometry is shown in Table 1 . There were 132 subjects with normal LV systolic function (ie, an ejection fraction X50%) and 58 subjects with asymptomatic LV systolic dysfunction. The majority of patients with asymptomatic LV systolic dysfunction (n ¼ 42) were in the hypertensive group with LV hypertrophy. When subjects with an ejection fraction X50% (n ¼ 132) were analysed separately, the ejection fraction values were 61 7 6, 58 7 5, and 59 7 6%, respectively. The corresponding values for the atrioventricular plane displacement in these subjects remained unchanged (cf Table 1 ).
Comparisons of the normotensive group and the two hypertensive groups
The reduction in diastolic function was progressive from the normotensive group to the hypertensive group without LV hypertrophy, and further to the hypertensive group with LV hypertrophy (Table 1 and Figure 1 ). Diastolic function decreased with . E/A-ratio, ratio of peak of early (E) and peak of late (A) mitral inflow velocities; E-dec, E wave deceleration time; IVRT, isovolumic relaxation time; AV-LA/AVmean, ratio of the magnitude of motion due to atrial systole to the total diastolic atrioventricular plane displacement. Essentially, the same results were obtained when subjects with asymptomatic LV systolic dysfunction were excluded. Mean values 7 s.d., *Po0.05, **Po0.01, ***Po0.001. increasing age (ie, r ¼ -0.48 for the E/A-ratio, r ¼ 0.34 for E-dec, r ¼ 0.23 for IVRT, and r ¼ 0.51 for AV-LA/ AV-mean, by univariate analyses; Po0.01 for all). An inverse relation between diastolic function and heart rate was also found for E/A and AV-LA/AVmean (r ¼ -0.29 and 0.39, respectively, by univariate analyses; both Po0.001), but not for E-dec (r ¼ 0.06) and IVRT (r ¼ 0.09).
Univariate relations between diastolic function, as evaluated by the E/A-ratio and IVRT, and systolic blood pressure and pulse pressure are presented in Figure 2 .
001).
The E/A-ratio was inversely related to LV wall thickness, as assessed by IVS, LV mass index and RWT (Figure 2a) , or by PWT (r ¼ -0.35, Po0.001). Similar relations were obtained between IVRT and IVS, LV mass index and RWT (Figure 2b ), and PWT (r ¼ 0.32, Po0.001). However, the E/A-ratio and IVRT did not relate to LVEDD (Figure 2) . IVRT was weakly but significantly correlated to ejection fraction (ie, r ¼ 0.15, P ¼ 0.044), whereas E/A-ratio, Edec and AV-LA/AV-mean were not related to ejection fraction. When diastolic function was evaluated by E-dec and AV-LA/AV-mean, similar but slightly weaker significant correlations than those found for the E/A-ratio were obtained (data not shown).
The relations between diastolic function on the one hand, and blood pressure and determinants of LV geometry on the other, were evaluated in a stepwise regression model ( Table 2 ). Age was the strongest determinant for the E/A-ratio, E-dec and AV-LA/AV-mean, followed by systolic blood pressure, heart rate and RWT (for E/A-ratio and E-dec). For IVRT, however, RWT appeared the Stepwise regression analysis on 176 subjects, where R 2 stands for the whole model. SBP, systolic blood pressure; RWT, relative wall thickness. Diastolic function in hypertension R Müller-Brunotte et al strongest determinant, followed by systolic blood pressure and age. Also when the two hypertensive groups were analysed separately, age remained the strongest factor for the E/A-ratio, E-dec and AV-LA/AV-mean, and RWT the strongest factor for IVRT. As expected, RWT was more important than systolic blood pressure for all four indices of diastolic function when the hypertensive groups were assessed separately. Body mass index, ejection fraction and gender did not contribute significantly to the results of the multivariate analyses.
Relations between diastolic function various LV geometric patterns
When the study subjects were grouped according to the LV geometric patterns, the four groups (ie, normal, LV remodelling, eccentric and concentric LV hypertrophy) were well matched for gender and age (Table 3 ). However, body mass index was greater in the group with concentric LV hypertrophy, as compared to those with normal LV geometry (Po0.01). The concentric group also had the highest blood pressure levels (Table 3) .
Hypertensive subjects with concentric LV hypertrophy displayed a depressed diastolic function, as compared to subjects with normal LV geometry ( Figure 3 ). Subjects with LV remodelling and eccentric LV hypertrophy were in an intermediate group with regard to indices of diastolic function.
The ejection fraction was lower in the group with concentric LV hypertrophy, as compared to subjects with normal LV geometry (Po0.001). Similarly, when systolic function was measured by the atrioventricular plane displacement method, LV systolic function was lower in all groups with abnormal geometric patterns (Po0.001 for concentric LV hypertrophy and LV remodelling, and Po0.01 for eccentric LV hypertrophy, as compared to the subjects with normal LV geometry).
Discussion
The present results show that hypertension is associated with LV diastolic dysfunction, and diastolic function is further impaired in the presence of hypertensive LV hypertrophy. Indeed, LV diastolic dysfunction is considered to be an early sign of hypertensive heart disease, and an inverse relation between LV hypertrophy and diastolic function is in agreement with earlier findings. [20] [21] [22] One major finding of this study is that both blood pressure and LV wall thickness independently influence diastolic function (as assessed by the E/ A-ratio, E-dec or IVRT). 23, 24 The present observation that increased blood pressure is related to impaired diastolic function demonstrates the haemodynamic influence of blood pressure on LV diastolic function. 21, 25 Thus, an elevated blood pressure will increase LV wall tension, which is a major determinant for myocardial hypertrophy and subsequent diastolic dysfunction. Pressure overload will also cause an impaired diastolic relaxation. 20 An increased heart rate is common in hypertension and will decrease diastolic function due to a reduced time for LV relaxation and filling. 26 In addition, an elevated blood pressure and a high heart rate could Figure 3 Evaluation of LV diastolic function in 63 subjects with normal geometry (normal), 13 with LV remodelling (LV Remod), 47 with eccentric LV hypertrophy (Ecc LVH) and 64 with concentric LV hypertrophy (Conc LVH). E/A-ratio, ratio of peak of early (E) and peak of late (A) mitral inflow velocities; E-dec, E wave deceleration time; IVRT, isovolumic relaxation time; AV-LA/AV-mean, ratio of the magnitude of motion due to atrial systole to the total diastolic atrioventricular plane displacement. Mean values 7 s.d., *Po0.05, **Po0.01, ***Po0.001.
reduce myocardial perfusion, which may contribute to diastolic dysfunction. The second important observation is that LV wall thickness (whether expressed as IVS, PWT or RWT) is inversely related to diastolic function (assessed by the E/A-ratio, E-dec or IVRT), independent of blood pressure. This suggests a role for raised LV mass on diastolic dysfunction. 27 Nonhaemodynamic factors can promote myocardial hypertrophy. Thus, angiotensin II and aldosterone can cause myocyte growth and fibrosis, 28 and there is a relation between determinants of the renin-angiotensin-aldosterone system and LV mass. [29] [30] [31] Indeed, an increased collagen content, structural remodelling of the fibrillar collagen matrix, interstitial oedema and myocardial fibrosis can provide the structural basis for diastolic dysfunction rather than the actual myocardial mass, suggesting that the quality rather than the quantity of tissue accounts for the pathologic cardiac hypertrophy.
When the patients were divided according to LV geometric pattern (cf Table 3 and Figure 3 ), the progressive impairment in LV dysfunction from the group with normal LV geometry to LV remodelling, eccentric LV hypertrophy and to concentric LV hypertrophy was accompanied by increases in both blood pressure and LV mass index. Our results could suggest that the degree of diastolic dysfunction reflect anatomic adaptation of LV geometric pattern and in particular the severity of LV hypertrophy. A more important factor for the abnormal relaxation pattern may, however, be the haemodynamic influence, such as myocardial wall stress, 21 or metabolic abnormalities. 32 The multivariate stepwise regression analyses show that age and systolic blood pressure are the most important factors to influence diastolic function, when determined by the E/A-ratio or E-dec. The E/A-ratio and E-dec are largely the results of the pressure gradient generated between the left atrium and ventricle shortly after the opening of the mitral valve. Thus, one could assume that an elevated systolic blood pressure and subsequent LV end systolic pressure alters this physiological pressure gradient, leading to impairment of LV diastolic function. When IVRT was used as an index of diastolic function, however, RWT was the most important factor for diastolic function, followed by systolic blood pressure. This is in agreement with findings by Wachtell et al 33 where a reduction in end diastolic RWT by antihypertensive treatment was associated with a reduction in IVRT, whereas a reduction in diastolic blood pressure was associated with an increase in the E/A-ratio. 33 Thus, different echocardiographic measurements of diastolic function are influenced by different factors.
We calculated RWT as (IVS+PWT)/LVEDD, and used a partition value of 40.45 to define concentric LV remodelling and hypertrophy. 15 Alternatively, RWT may be calculated as (2 Â PWT)/LVEDD and be considered increased if 40.43. 34 This method will somewhat shift the prevalence from concentric remodelling to normal LV geometry, and from concentric to eccentric LV hypertrophy. 35 Our findings were generally similar when the latter method was applied (data not shown). However, RWT calculated as (IVS+PWT)/LVEDD was preferred, since this includes both the septal and posterior aspects of the left chamber. This was considered important as it may best reflect global LV wall thickness in the presence of asymmetric LV remodelling due to septal thickness. 36 We obtained largely similar information on LV diastolic function, whether measured by the E/Aratio, E-dec or IVRT, suggesting these measures of diastolic function to be reliable and accurate. However, the E/A-ratio appeared to show less variability and may be a more sensitive measure of early LV diastolic dysfunction. Taken together, the E/A-ratio may be well suited to study early changes of diastolic function. E-dec and IVRT, on the other hand, are less dependent on heart rate, which may be an advantage under some circumstances.
Subjects with LV remodelling had an impaired diastolic function, as compared to those with a normal LV geometric pattern, when assessed by the atrioventricular plane displacement method. Alam and Hö glund 19 also showed that the AV-LA/AVmean is a useful measure of diastolic function in healthy subjects. However, our results suggest that the atrioventricular plane displacement method is less suitable to evaluate diastolic function in subjects with hypertensive LV hypertrophy, since AV-LA/AV-mean was not increased in hypertensive patients with LV hypertrophy, as compared to those with no LV hypertrophy. Interestingly, there is an underestimation of the ejection fraction as a measure of systolic LV function using the atrioventricular plane displacement method in patients with LV hypertrophy. 37 A probable explanation is that patients with LV hypertrophy and normal short axis shortening, in addition to a reduced long axis shortening, also have a reduced circumferential shortening measured from the mid-wall, indicating myocardial dysfunction. 38, 39 Thus, AV-LA/AV-mean may be a valuable measure of diastolic function in subjects with a normal LV mass, but is less suitable than other indices used in this study for the evaluation of diastolic function in subjects with LV hypertrophy.
Although our results of a lower ejection fraction in patients with hypertensive heart disease agree with some observations, 6 ,40 most studies report similar or even higher ejection fraction values in hypertensive patients than in normotensive subjects. 21, 41, 42 Differences in the study populations (eg, the duration and/or magnitude of blood pressure elevation, degree of LV hypertrophy, proportion of patients with asymptomatic LV systolic dysfunction, concomitant medication or age) or methodological reasons (the use of M-mode or 2D-mode echocardio-graphy) may contribute. Indeed, when subjects with an ejection fraction X50% were evaluated separately, we were able to confirm similar ejection fraction values in hypertensive patients and in normotensive subjects.
Our findings suggesting that both blood pressure and structural cardiac changes contribute to the development of LV diastolic dysfunction may be clinically important. This could help to explain why diastolic dysfunction could be an important contributor to acute hypertensive pulmonary oedema in patients with a normal LV ejection fraction. 43 Indeed, our results support observations that hypertension and its associated structural cardiac changes are important factors in the development of heart failure with preserved systolic function, which is a condition with a poor prognosis. 7, 44 Accordingly, echocardiographic signs of LV diastolic dysfunction can predict future cardiovascular morbidity and mortality. 45, 46 In conclusion, blood pressure and LV wall thickness independently influence diastolic function. Age and blood pressure are the most important factors to influence LV diastolic function, when determined by the E/A-ratio or E-dec, whereas LV geometry and blood pressure are most important when IVRT was used as an index of LV diastolic function. AV-LA/AV-mean may not be useful in evaluating diastolic function in patients with LV hypertrophy.
